Mark A. Fisher

1.3k total citations
37 papers, 787 citations indexed

About

Mark A. Fisher is a scholar working on Clinical Biochemistry, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark A. Fisher has authored 37 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Clinical Biochemistry, 14 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark A. Fisher's work include Bacterial Identification and Susceptibility Testing (15 papers), Infective Endocarditis Diagnosis and Management (9 papers) and Streptococcal Infections and Treatments (7 papers). Mark A. Fisher is often cited by papers focused on Bacterial Identification and Susceptibility Testing (15 papers), Infective Endocarditis Diagnosis and Management (9 papers) and Streptococcal Infections and Treatments (7 papers). Mark A. Fisher collaborates with scholars based in United States, Australia and Denmark. Mark A. Fisher's co-authors include Marc Roger Couturier, Ann Croft, Prasanna D. Khot, Robert J. Fallis, Robert Schlaberg, Keith E. Simmon, Andrew Wilson, Kelly F. Oakeson, Colin Dale and Adam L. Clayton and has published in prestigious journals such as Nature Communications, Neurology and Journal of Clinical Microbiology.

In The Last Decade

Mark A. Fisher

36 papers receiving 770 citations

Peers

Countries citing papers authored by Mark A. Fisher

Since Specialization

Citations

This map shows the geographic impact of Mark A. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Fisher more than expected).

Fields of papers citing papers by Mark A. Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Fisher. The network helps show where Mark A. Fisher may publish in the future.

Co-authorship network of co-authors of Mark A. Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Fisher. A scholar is included among the top collaborators of Mark A. Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Fisher. Mark A. Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of disk diffusion susceptibility test methods for Aerococcus spp. and updates to Clinical and Laboratory Standards Institute MIC breakpoints 2025 ·Journal of Clinical Microbiology ·(unknown), (unknown), (unknown), (unknown), Nathan A. Ledeboer, Patricia J. Simner, Mark A. Fisher, Romney M. Humphries	0
2	Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin 2023 ·Microbiology Spectrum ·(unknown), Bailey W. Miller, Zhenjian Lin, Mark A. Fisher, Louis R. Barrows, Margo G. Haygood, Eric W. Schmidt	2
3	Evaluation of the LifeScale system for rapid phenotypic antimicrobial susceptibility testing from positive blood cultures 2023 ·American Journal of Clinical Pathology ·Daniel Montelongo‐Jauregui, E. Susan Slechta, Mark A. Fisher	2
4	128. Validation of a rapid diagnostics platform for detecting extended-spectrum beta-lactamase resistance in gram negative bacteremia 2023 ·Open Forum Infectious Diseases ·(unknown), Tristan T. Timbrook, Mark A. Fisher, (unknown)	1
5	Flukebook: an open-source AI platform for cetacean photo identification 2022 ·Mammalian Biology ·(unknown), Shane Gero, (unknown), (unknown), (unknown), (unknown), (unknown), Mark A. Fisher, Gianna Minton, Christin Brangwynne Khan, (unknown), (unknown), (unknown), Tanya Berger‐Wolf, Charles V. Stewart, Jason Holmberg, (unknown)	35
6	Platelet Component False Positive Detection Rate in Aerobic and Anaerobic Primary Culture: A Systematic Review and Meta-Analysis 2021 ·Transfusion Medicine Reviews ·(unknown), Sandra White, Robert L. Schmidt, Brandon S. Walker, Mark A. Fisher, Ryan A. Metcalf	2
7	Yersinia pestis Lipopolysaccharide Remodeling Confers Resistance to a Xenopsylla cheopis Cecropin 2021 ·ACS Infectious Diseases ·(unknown), (unknown), Mark A. Fisher	5
8	Characterization of six clinical isolates of Chimaeribacter gen. nov., a novel genus related to the Yersiniaceae family and the three species Chimaeribacter arupi sp. nov., Chimaeribacter coloradensis sp. nov, and Chimaeribacter californicus sp. nov. 2020 ·INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY ·Alessandro Rossi, Mark A. Fisher	5
9	Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection 2019 ·Nature Communications ·Brian M. Forde, Leah W. Roberts, Minh‐Duy Phan, Kate M. Peters, Brittany A. Fleming, (unknown), Sara Lenherr, Jeremy B. Myers, Adam P. Barker, Mark A. Fisher, Teik-Min Chong, Wai‐Fong Yin, Kok‐Gan Chan, Mark A. Schembri, Matthew A. Mulvey, Scott A. Beatson	87
10	Antimicrobial Susceptibility Patterns among a Large, Nationwide Cohort of Abiotrophia and Granulicatella Clinical Isolates 2017 ·Journal of Clinical Microbiology ·(unknown), Mark A. Fisher	18
11	An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy 2015 ·World Journal of Urology ·Stephen J. Summers, Darshan P. Patel, Blake D. Hamilton, Angela P. Presson, Mark A. Fisher, William T. Lowrance, Andrew Southwick	22
12	Identification of Nocardia Species by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry 2015 ·Journal of Clinical Microbiology ·Prasanna D. Khot, (unknown), Robert J. Durrant, Mark A. Fisher	32
13	LPS modification promotes maintenance of Yersinia pestis in fleas 2014 ·Microbiology ·(unknown), John A. Montenieri, Mark A. Fisher, Scott W. Bearden, Benjamin D. Brooks, Kenneth L. Gage	27
14	Polymer-controlled release of tobramycin from bone graft void filler 2013 ·Drug Delivery and Translational Research ·Amanda E. Brooks, Benjamin D. Brooks, (unknown), (unknown), Mark A. Fisher, David W. Grainger	12
15	Detection of non- jejuni and -coli Campylobacter Species from Stool Specimens with an Immunochromatographic Antigen Detection Assay 2013 ·Journal of Clinical Microbiology ·Brianne Couturier, Marc Roger Couturier, (unknown), Mark A. Fisher	10
16	A Novel Human-Infection-Derived Bacterium Provides Insights into the Evolutionary Origins of Mutualistic Insect–Bacterial Symbioses 2012 ·PLoS Genetics ·Adam L. Clayton, Kelly F. Oakeson, (unknown), (unknown), Diane M. Dunn, (unknown), Robert B. Weiss, Mark A. Fisher, Colin Dale	103
17	A Systematic Approach for Discovering Novel, Clinically Relevant Bacteria 2012 ·Emerging infectious diseases ·Robert Schlaberg, Keith E. Simmon, Mark A. Fisher	59
18	Isolation and Identification of Kroppenstedtia eburnea Isolates from Multiple Patient Samples 2012 ·Journal of Clinical Microbiology ·Adam P. Barker, Keith E. Simmon, (unknown), E. Susan Slechta, Mark A. Fisher, Robert Schlaberg	5
19	Defining Plasmids Required by <I>Borrelia burgdorferi</I> for Colonization of Tick Vector <I>Ixodes scapularis</I> (Acari: Ixodidae) 2005 ·Journal of Medical Entomology ·Dorothee Grimm, Kit Tilly, Dawn M. Bueschel, Mark A. Fisher, Paul F. Policastro, Frank C. Gherardini, Tom G. Schwan, Patricia A. Rosa	50
20	Silent erosive esophagitis with severe iron-deficiency anemia. 1980 ·PubMed ·Mark A. Fisher, S Katz, Irwin Katzka	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact